Search results
Is IPSEN (IPSEY) Outperforming Other Medical Stocks This Year?
Zacks via Yahoo Finance· 1 year agoFor those looking to find strong Medical stocks, it is prudent to search for companies in the group...
Epizyme (EPZM) Stock Surges on Acquisition Offer From Ipsen
Zacks via Yahoo Finance· 2 years agoIpsen, through its wholly-owned subsidiary, is set to acquire Epizyme (EPZM) for $1.45 per share, in...
Ipsen, Genfit's Elafibranor Shows Promise In Primary Biliary Cholangitis Patients
Benzinga via Yahoo Finance· 12 months agoIpsen SA (OTC: IPSEY) and Genfit SA (NASDAQ: GNFT) announced topline data from the Phase 3 ELATIVE...
France-Based Ipsen Acquires Albireo Pharma Enriching Its Rare Disease Portfolio, Pipeline
Benzinga via Yahoo Finance· 1 year agoIpsen (OTC: IPSEY) has agreed to acquire Albireo Pharma Inc (NASDAQ: ALBO) at $42.00 per share in...
Ipsen Scoops Up Blood Cancer-Focused Epizyme - Read Why
Benzinga via Yahoo Finance· 2 years agoIpsen SA (OTC: IPSEY) has agreed to acquire Epizyme Inc (NASDAQ: EPZM) at $1.45 per share for...
Biotech Stock Roundup: EPZM Soars on IPSEY Offer, KZR Up on Study Data & More
Zacks via Yahoo Finance· 2 years agoThe biotech sector has been in the spotlight in the past week with important pipeline and regulatory...
Merrimack Pharma-Ipsen's Cancer Drug Fails In Overall Survival Measure
Benzinga via Yahoo Finance· 2 years agoMerrimack Pharmaceuticals Inc's (NASDAQ: MACK) partner announced that Ipsen SA (OTC: IPSEY) reported...
AbbVie, Ipsen Terminate Partnerships With Exicure As Bankruptcy Concern Looms
Benzinga via Yahoo Finance· 2 years agoExicure Inc (NASDAQ: XCUR) announced the termination of its collaboration agreements with AbbVie Inc...
Biotech Stock Roundup: MACK Up on Study Data, MRNA Offers Vaccine Update & More
Zacks via Yahoo Finance· 2 years agoDrug approvals and other regulatory news are in focus in the biotech sector. Updates on booster...
Why These Two Biotech Stocks Blasted Higher This Week
Motley Fool· 1 year agoTwo somewhat under-the-radar biotech companies saw their share prices soar this week after agreeing...